September 27, 2025 a 06:00 pm
BDX: Fundamental Ratio Analysis - Becton, Dickinson and Company
Becton, Dickinson and Company, a leading player in medical supplies and diagnostic products, offers a solid portfolio with robust segment performance. Despite market fluctuations, BDX maintains steady growth with innovative healthcare solutions. Investors view it as a stable, long-term asset in the healthcare industry.
Fundamentals Rating
The company exhibits a balanced score with strengths in discounted cash flow and return on assets, albeit some concerns with debt to equity.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 3 |
Historical Rating
Comparing historical ratings reveals consistent discounted cash flow performance, while other metrics show room for improvement.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-09-26 | 3 | 5 | 3 | 4 | 1 | 1 | 3 |
Analyst Price Targets
Analysts offer steady price targets with a consensus on the stock’s valuation remaining constant.
| High | Low | Median | Consensus |
|---|---|---|---|
| 260 | 260 | 260 | 260 |
Analyst Sentiments
The consensus remains positive for Becton, Dickinson and Company, with most analysts recommending a buy.
| Rating | Number of Recommendations | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 16 | |
| Hold | 15 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Becton, Dickinson and Company's stock exhibits solid fundamentals with particularly strong performance in discounted cash flow metrics. The stable analyst price targets reflect confidence in the company's performance potential. However, concerns around debt to equity ratios suggest a need for careful capital management. Overall, BDX is regarded as a reliable investment option within the healthcare sector, particularly appealing to long-term investors focused on stability rather than high yield. The consensus from analysts remains bullish, further reinforcing the stock's potential for sustained growth.